Joshua H. Bilenker, President & CEO at Loxo Oncology, Inc. (LOXO), sold 7,500 shares at $133.49 ($985K) on 2018-04-24, disclosed to the SEC on 2018-04-26.
Open-market sale of $985k LOXO by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $129.35 | 1,717 | $222K | 22.5% |
| 2 | $130.62 | 1,283 | $168K | 17.0% |
| 3 | $131.76 | 1,500 | $198K | 20.1% |
| 4 | $132.54 | 2,490 | $330K | 33.5% |
| 5 | $133.49 | 510 | $68K | 6.9% |
| Total | $131.39 avg | 7,500 |
| $985K |
| 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $2.7M | — | Filing → |
| LOXO | SELL | 2018-12-12 | $1.0M | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.2M | — | Filing → |